![TBCG at the COGNO ASM 2022](https://images.prismic.io/the-brain-cancer-group/3705a63c-2c6d-4d17-97fa-bf5a70ba91ef_TBCG_COGNO_01.jpg?ixlib=gatsbyFP&auto=compress%2Cformat&fit=max&w=1280&h=960)
The Brain Cancer Group had the privilege to take up the Platinum Sponsorship at the Cooperative Trials Group for Neuro-Oncology (COGNO) 14th Annual Scientific Meeting in Brisbane Queensland last week.
The organisers were delighted to be meeting face-to-face once more and for the opportunity to meaningfully reconnect and refocus on the significance of COGNO in Australasia today.
A large team of TBCG doctors, researchers & support staff and our Community Ambassador Cassandra Bennett attended.
The exciting program featured acclaimed international and local speakers. Presentations covered a wide range of neuro-oncology topics such as translational science, novel therapies, and supportive care. New sessions were also scheduled to delve deeper into spinal oncology, medicinal cannabis, and a special education workshop for trainees.
In the photos Associate Professor Michael Back, Dr Helen Wheeler, Dr Jonathon Parkinson, Dr Adrian Lee and recipients of TBCG's Travel & Education Grants: Dr Jackie Yim, Dr Julius Kim, Dr Alex Yuile, Dr Amanda Hudson, research assistant Sanderijn Engel and Neuro Oncology Nurse Practitioner Marina Kastelan and Brain Cancer Nurse Coordinator Nicola Cove.
![TBCG at the COGNO ASM 2022](https://images.prismic.io/the-brain-cancer-group/02ec14ae-8a02-44ef-97c9-7daee5de3fa7_TBCG_COGNO_03.jpg?ixlib=gatsbyFP&auto=compress%2Cformat&fit=max&w=2048&h=1150)
![TBCG at the COGNO ASM 2022](https://images.prismic.io/the-brain-cancer-group/a9fe9b6f-203b-43cd-861e-a4946c998b2c_TBCG_COGNO_02.jpg?ixlib=gatsbyFP&auto=compress%2Cformat&fit=max&w=1600&h=1200)
![TBCG at the COGNO ASM 2022](https://images.prismic.io/the-brain-cancer-group/e6f6a4f9-acf0-4e1d-8341-8b4ffa7da69b_TBCG_COGNO_07.jpg?ixlib=gatsbyFP&auto=compress%2Cformat&fit=max&w=2048&h=1536)
![TBCG at the COGNO ASM 2022](https://images.prismic.io/the-brain-cancer-group/57ad5688-cbee-45b5-95a2-d5a5e70b6094_TBCG_COGNO_06.jpg?ixlib=gatsbyFP&auto=compress%2Cformat&fit=max&w=2048&h=1150)
![TBCG at the COGNO ASM 2022](https://images.prismic.io/the-brain-cancer-group/277acc25-ae3e-46af-9466-ae41d985ce5d_TBCG_COGNO_08.jpg?ixlib=gatsbyFP&auto=compress%2Cformat&fit=max&w=2048&h=1150)
![TBCG at the COGNO ASM 2022](https://images.prismic.io/the-brain-cancer-group/ea5f8fcf-6527-48bf-adf1-1c2769c800c6_TBCG_COGNO_04.jpg?ixlib=gatsbyFP&auto=compress%2Cformat&fit=max&w=2048&h=2048)
![TBCG at the COGNO ASM 2022](https://images.prismic.io/the-brain-cancer-group/35400b52-586f-4965-8056-3a1698ac7d38_TBCG_COGNO_09.jpg?ixlib=gatsbyFP&auto=compress%2Cformat&fit=max&w=2048&h=1152)
![TBCG at the COGNO ASM 2022](https://images.prismic.io/the-brain-cancer-group/4d2a46e2-ffb5-42a1-83ed-fc51773475ca_TBCG_COGNO_10.jpg?ixlib=gatsbyFP&auto=compress%2Cformat&fit=max&w=2048&h=1536)
![TBCG at the COGNO ASM 2022](https://images.prismic.io/the-brain-cancer-group/2f1acafe-7b37-4289-b797-f02471545338_TBCG_COGNO_11.jpg?ixlib=gatsbyFP&auto=compress%2Cformat&fit=max&w=2048&h=1152)
![TBCG at the COGNO ASM 2022](https://images.prismic.io/the-brain-cancer-group/48dfc6a3-8d20-4e82-87c3-bb157e4c4377_TBCG_COGNO_05.jpg?ixlib=gatsbyFP&auto=compress%2Cformat&fit=max&w=1600&h=1200)